# Naltrexone for Nonsuicidal Self-Injury

> **NCT07641283** · NA · NOT_YET_RECRUITING · sponsor: **Seoul National University Hospital** · enrollment: 150 (estimated)

## Conditions studied

- Nonsuicidal Self-Injury
- Self-Injurious Behavior

## Interventions

- **DRUG:** Naltrexone 50mg (Whanin Naltrexone Tab. 50mg)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07641283
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06
- **Primary completion:** 2027-12
- **Final completion:** 2028-06
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2026-06-11

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07641283

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07641283, "Naltrexone for Nonsuicidal Self-Injury". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07641283. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*